Lithium for the 2019 novel coronavirus.
作者信息
Gómez-Bernal Germán
机构信息
CRP San Jaun de Dios, Servicio Aragonés de Salud, Spain.
出版信息
Med Hypotheses. 2020 Sep;142:109822. doi: 10.1016/j.mehy.2020.109822. Epub 2020 May 7.
Abstract
摘要
相似文献
1
Lithium for the 2019 novel coronavirus.锂用于治疗2019新型冠状病毒。 （不过从专业角度看，该表述不太符合医学常理，可能存在信息偏差，仅按要求翻译）
Med Hypotheses. 2020 Sep;142:109822. doi: 10.1016/j.mehy.2020.109822. Epub 2020 May 7.
2
Therapeutic efficacy of Pudilan Xiaoyan Oral Liquid (PDL) for COVID-19 in vitro and in vivo.蒲地蓝消炎口服液（PDL）对新型冠状病毒肺炎的体内外治疗效果
Signal Transduct Target Ther. 2020 May 8;5(1):66. doi: 10.1038/s41392-020-0176-0.
3
Inhibition of SARS-CoV-2 Infection by the Cyclophilin Inhibitor Alisporivir (Debio 025).环孢素抑制剂阿利匹韦（Debio 025）抑制 SARS-CoV-2 感染。
Antimicrob Agents Chemother. 2020 Jun 23;64(7). doi: 10.1128/AAC.00876-20.
4
Effects of Gene-Eden-VIR and Novirin on SARS-CoV: Implications for COVID-19.基因伊甸-VIR和诺维林对严重急性呼吸综合征冠状病毒的作用：对2019冠状病毒病的启示。
J Evid Based Integr Med. 2020 Jan-Dec;25:2515690X20932523. doi: 10.1177/2515690X20932523.
5
Targeting SARS-CoV-2 using polycomb inhibitors as antiviral agents.使用多梳蛋白抑制剂作为抗病毒药物靶向严重急性呼吸综合征冠状病毒2（SARS-CoV-2）
Epigenomics. 2020 May;12(10):811-812. doi: 10.2217/epi-2020-0154. Epub 2020 Jun 4.
6
SARS-CoV-2 and the safety margins of cell-based biological medicinal products.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）与基于细胞的生物药品的安全边际
Biologicals. 2020 Nov;68:122-124. doi: 10.1016/j.biologicals.2020.08.010. Epub 2020 Aug 29.
7
[Not Available].[无可用内容]
Rev Med Suisse. 2020 Mar 11;16(685):510-511.
8
Interferon-β-1a Inhibition of Severe Acute Respiratory Syndrome-Coronavirus 2 In Vitro When Administered After Virus Infection.干扰素-β-1a 对病毒感染后给药时体外严重急性呼吸综合征冠状病毒 2 的抑制作用。
J Infect Dis. 2020 Aug 4;222(5):722-725. doi: 10.1093/infdis/jiaa350.
9
[SARS-CoV-2 protease: an excellent target to develop drugs against COVID-19].[严重急性呼吸综合征冠状病毒2蛋白酶：开发抗2019冠状病毒病药物的理想靶点]
Med Sci (Paris). 2020 Jun-Jul;36(6-7):555-558. doi: 10.1051/medsci/2020106. Epub 2020 Jun 19.
10
Structural Biology Aids the Research of New Anti-COVID-19 Drugs.结构生物学助力新型抗新冠病毒药物的研究。
Curr Org Synth. 2020;17(3):162-163. doi: 10.2174/157017941703200610221527.
引用本文的文献
1
Exploring the Neuroprotective Effects of Lithium in Ischemic Stroke: A literature review.探讨锂在缺血性脑卒中的神经保护作用：文献综述。
Int J Med Sci. 2024 Jan 1;21(2):284-298. doi: 10.7150/ijms.88195. eCollection 2024.
2
Molecular mechanisms and therapeutic effects of different vitamins and minerals in COVID-19 patients.不同维生素和矿物质在 COVID-19 患者中的分子机制和治疗效果。
J Trace Elem Med Biol. 2022 Sep;73:127044. doi: 10.1016/j.jtemb.2022.127044. Epub 2022 Jul 20.
3
Efficacy and Safety of Lithium Treatment in SARS-CoV-2 Infected Patients.锂治疗对新冠病毒感染患者的疗效与安全性
Front Pharmacol. 2022 Apr 14;13:850583. doi: 10.3389/fphar.2022.850583. eCollection 2022.
本文引用的文献
1
Antiviral effect of lithium chloride on porcine epidemic diarrhea virus in vitro.氯化锂对猪流行性腹泻病毒的体外抗病毒作用
Res Vet Sci. 2018 Jun;118:288-294. doi: 10.1016/j.rvsc.2018.03.002. Epub 2018 Mar 5.
2
Comparative analysis of the effect of glycyrrhizin diammonium and lithium chloride on infectious bronchitis virus infection in vitro.甘草酸二铵与氯化锂对体外传染性支气管炎病毒感染影响的比较分析
Avian Pathol. 2009 Jun;38(3):215-21. doi: 10.1080/03079450902912184.
3
Lithium chloride inhibits the coronavirus infectious bronchitis virus in cell culture.氯化锂在细胞培养中可抑制冠状病毒性传染性支气管炎病毒。
Avian Pathol. 2007 Apr;36(2):109-14. doi: 10.1080/03079450601156083.
Zotero 插件